Published in Am J Med Genet on March 08, 2001
Assessing the molecular genetics of attention networks. BMC Neurosci (2002) 2.02
Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci Biobehav Rev (2009) 1.57
A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neurosci Biobehav Rev (2007) 1.29
GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology (Berl) (2009) 1.14
Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans. Mol Psychiatry (2009) 1.08
Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo. Cell Mol Neurobiol (2006) 1.05
Predictive animal models of mania: hits, misses and future directions. Br J Pharmacol (2011) 1.04
The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Pharmacol Biochem Behav (2010) 1.02
Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania. J Psychopharmacol (2011) 1.00
Rodent versions of the iowa gambling task: opportunities and challenges for the understanding of decision-making. Front Neurosci (2011) 0.99
Cross-species assessments of motor and exploratory behavior related to bipolar disorder. Neurosci Biobehav Rev (2010) 0.97
Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice. Behav Pharmacol (2008) 0.97
Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS). Mol Neurobiol (2014) 0.96
Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder. BMC Med Genet (2010) 0.93
Dopamine transporter gene may be associated with bipolar disorder and its personality traits. Eur Arch Psychiatry Clin Neurosci (2014) 0.93
Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania. Psychopharmacology (Berl) (2012) 0.90
MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice. Psychopharmacology (Berl) (2004) 0.88
Glial cell line-derived neurotrophic factor (GDNF) as a novel candidate gene of anxiety. PLoS One (2013) 0.88
The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited. Eur J Pharmacol (2014) 0.86
Family-based study of markers at the 5'-flanking region of the human dopamine transporter gene reveals potential association with schizophrenic psychoses. Eur Arch Psychiatry Clin Neurosci (2006) 0.84
Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats. Neuropharmacology (2011) 0.84
Pharmacogenetics of antidepressants. Front Pharmacol (2011) 0.82
Association of TPH1 with suicidal behaviour and psychiatric disorders in the Chinese population. J Med Genet (2006) 0.82
Visualization of the cocaine-sensitive dopamine transporter with ligand-conjugated quantum dots. ACS Chem Neurosci (2011) 0.82
Pharmacogenomic strategy for individualizing antidepressant therapy. Dialogues Clin Neurosci (2008) 0.81
Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophr Res (2015) 0.78
Amphetamine increases activity but not exploration in humans and mice. Psychopharmacology (Berl) (2015) 0.77
Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2012) 0.77
Excited Delirium and Sudden Death: A Syndromal Disorder at the Extreme End of the Neuropsychiatric Continuum. Front Physiol (2016) 0.76
Positive Traits in the Bipolar Spectrum: The Space between Madness and Genius. Mol Neuropsychiatry (2016) 0.75
Dopamine transporter mutant animals: a translational perspective. J Neurogenet (2016) 0.75
MAP kinase pathways in the yeast Saccharomyces cerevisiae. Microbiol Mol Biol Rev (1998) 6.20
Biodegradation: problems of molecular recalcitrance and microbial fallibility. Adv Appl Microbiol (1965) 5.67
Effect of concentration of organic chemicals on their biodegradation by natural microbial communities. Appl Environ Microbiol (1979) 5.36
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol (1990) 5.26
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry (2000) 5.21
Biodegradation of chemicals of environmental concern. Science (1981) 5.19
Kinetics and extent of mineralization of organic chemicals at trace levels in freshwater and sewage. Appl Environ Microbiol (1982) 5.13
Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry (1993) 4.57
Minimum bacterial density for bacteriophage replication: implications for significance of bacteriophages in natural ecosystems. Appl Environ Microbiol (1985) 4.26
Detection and identification of bacteria by gas chromatography. Appl Microbiol (1966) 3.70
Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry (2009) 3.64
A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature (1995) 3.57
Protozoa as agents responsible for the decline of Xanthomonas campestris in soil. Appl Microbiol (1975) 3.52
Protozoa and the decline of Rhizobium populations added to soil. Can J Microbiol (1975) 3.47
Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet (2004) 3.47
Relationship between Cell Surface Properties and Transport of Bacteria through Soil. Appl Environ Microbiol (1991) 3.43
Aerobic cometabolism of DDT analogues by Hydrogenomonas sp. J Agric Food Chem (1971) 3.43
Models for mineralization kinetics with the variables of substrate concentration and population density. Appl Environ Microbiol (1984) 3.41
Further evidence for the regulation of bacterial populations in soil by protozoa. Arch Microbiol (1977) 3.36
Fate in model ecosystems of microbial species of potential use in genetic engineering. Appl Environ Microbiol (1982) 3.32
Estimating the density of individual bacterial populations introduced into natural ecosytems. Can J Microbiol (1973) 3.27
Psychiatric features of individuals with problematic internet use. J Affect Disord (2000) 3.19
Why microbial predators and parasites do not eliminate their prey and hosts. Annu Rev Microbiol (1981) 3.18
Dissolution of fungal cell walls by a streptomycete chitinase and beta-(1-3) glucanase. Arch Biochem Biophys (1965) 3.14
Microbial transformation of nitroaromatic compounds in sewage effluent. Appl Environ Microbiol (1983) 3.12
A full genome search in multiple sclerosis. Nat Genet (1996) 2.96
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand (2007) 2.89
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry (2000) 2.88
Reasons for possible failure of inoculation to enhance biodegradation. Appl Environ Microbiol (1985) 2.82
Rates of mineralization of trace concentrations of aromatic compounds in lake water and sewage samples. Appl Environ Microbiol (1982) 2.81
Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry (1992) 2.70
Regulation of predation by prey density: the protozoan-Rhizobium relationship. Appl Microbiol (1975) 2.69
Phenols as intermediates in the decomposition of phenoxyacetates by an Arthrobacter species. Can J Microbiol (1967) 2.61
A population-based study of multiple sclerosis in twins. N Engl J Med (1986) 2.59
Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A (2003) 2.50
Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry (2008) 2.50
Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry (2003) 2.49
Phosphonate utilization by bacteria. J Bacteriol (1978) 2.46
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43
Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem (1988) 2.41
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry (2001) 2.38
Head injury and the risk of AD in the MIRAGE study. Neurology (2000) 2.34
Cometabolism of m-chlorobenzoate by an Arthrobacter. Appl Microbiol (1970) 2.34
Permeability of Nitrobacter agilis to Organic Compounds. J Bacteriol (1965) 2.31
Effects of dissolved organic carbon and second substrates on the biodegradation of organic compounds at low concentrations. Appl Environ Microbiol (1985) 2.31
Compulsive buying: a report of 20 cases. J Clin Psychiatry (1994) 2.29
DDT metabolites and analogs: ring fission by Hydrogenomonas. Science (1970) 2.26
Priorities in patient-care research and continuing medical education. JAMA (1968) 2.26
Extensive microbial degradation of DDT in vitro and DDT metabolism by natural communities. J Agric Food Chem (1972) 2.22
Evidence Suggesting Protozoan Predation on Rhizobium Associated with Germinating Seeds and in the Rhizosphere of Beans (Phaseolus vulgaris L.). Appl Environ Microbiol (1980) 2.21
Continuing education and patient care research. Physician response to screening test results. JAMA (1967) 2.16
Models for the kinetics of biodegradation of organic compounds not supporting growth. Appl Environ Microbiol (1985) 2.16
Formation of tumor-like structures on legume roots by Rhizobium. J Bacteriol (1971) 2.10
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Sleep and cardiorespiratory characteristics of infant victims of sudden death: a prospective case-control study. Sleep (1992) 2.07
Survival of Rhizobium in Acid soils. Appl Environ Microbiol (1981) 2.04
Phosphorus-containing pesticide breakdown products: quantitative utilization as phosphorus sources by bacteria. Appl Environ Microbiol (1978) 2.02
Biodegradation by an arthrobacter species of hydrocarbons partitioned into an organic solvent. Appl Environ Microbiol (1991) 1.95
Fingerprinting Acinetobacter strains from clinical sources by numerical analysis of electrophoretic protein patterns. J Med Microbiol (1984) 1.92
Rapid and sensitive detection of bacteria by gas chromatography. Appl Microbiol (1968) 1.92
Microbial degradation of polyethylene glycols. Appl Microbiol (1975) 1.91
Pharmacological treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol (1989) 1.91
Rates of dissolution and biodegradation of water-insoluble organic compounds. Appl Environ Microbiol (1986) 1.90
Parent-of-origin effects in MS: observations from avuncular pairs. Neurology (2008) 1.86
Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology (1996) 1.85
Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants. Mol Psychiatry (2012) 1.84
Effect of nutrient additions on the apparent cometabolism of DDT. J Agric Food Chem (1973) 1.82
Depression and multiple sclerosis. Neurology (1996) 1.79
Role of dissolution rate and solubility in biodegradation of aromatic compounds. Appl Environ Microbiol (1987) 1.78
Effect of sodium chloride on transport of bacteria in a saturated aquifer material. Appl Environ Microbiol (1991) 1.78
Effect of aging of chemicals in soil on their biodegradability and extractability. Environ Sci Technol (1995) 1.78
Explanations for the acclimation period preceding the mineralization of organic chemicals in aquatic environments. Appl Environ Microbiol (1987) 1.77
Conjugal multiple sclerosis: population-based prevalence and recurrence risks in offspring. Canadian Collaborative Study Group. Ann Neurol (2000) 1.75
Bipolar disorder: evidence for a major locus. Am J Med Genet (1995) 1.73
Stability of nitrosamines in samples of lake water, soil, and sewage. J Natl Cancer Inst (1975) 1.73
Microbial metabolism of carbon monoxide in culture and in soil. Appl Environ Microbiol (1979) 1.72
Heterotrophic nitrifiction by Arthrobacter sp. J Bacteriol (1972) 1.71
CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry (2001) 1.71
Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach. Physiol Genomics (2000) 1.71
Insulin regulation of protein biosynthesis in differentiated 3T3 adipocytes. Regulation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem (1985) 1.68
Kinetics of p-nitrophenol mineralization by a Pseudomonas sp.: effects of second substrates. Appl Environ Microbiol (1987) 1.68
Clinical and laboratory features and response to treatment in patients presenting with vitamin B12 deficiency-related neurological syndromes. Neurol India (2005) 1.66
Susceptibility and resistance of several fungi to microbial lysis. J Bacteriol (1966) 1.66
Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry (2011) 1.65
Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology (2001) 1.64
A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci U S A (2001) 1.64
Microbial metabolism of N-nitrosodiethanolamine in lake water and sewage. Appl Environ Microbiol (1980) 1.64
Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry (1996) 1.62
Rapid remission of OCD with tramadol hydrochloride. Am J Psychiatry (1999) 1.61
Effects of low concentrations of bisulfite-sulfite and nitrite on microorganisms. Appl Environ Microbiol (1978) 1.59
Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med (1992) 1.58
The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry (1999) 1.58
A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull (1994) 1.58
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry (2006) 1.58
Minimizing and managing antidepressant side effects. J Clin Psychiatry (1995) 1.57
A cost-benefit analysis of prenatal detection of Down syndrome and neural tube defects in older mothers. Am J Med Genet (1981) 1.57